000 | 01099 a2200289 4500 | ||
---|---|---|---|
005 | 20250517182630.0 | ||
264 | 0 | _c20190417 | |
008 | 201904s 0 0 eng d | ||
022 | _a1545-5017 | ||
024 | 7 |
_a10.1002/pbc.26807 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaj, Mary | |
245 | 0 | 0 |
_aReply to: Role of PET-CT in management of post-transplant lymphoproliferative disorder: Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder. _h[electronic resource] |
260 |
_bPediatric blood & cancer _c02 2018 |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphoma |
650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
650 | 0 | 4 | _aPositron-Emission Tomography |
700 | 1 | _aGuerra-Garcia, Pilar | |
700 | 1 | _aHirsch, Steffen | |
700 | 1 | _aLevine, Daniel | |
773 | 0 |
_tPediatric blood & cancer _gvol. 65 _gno. 2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.26807 _zAvailable from publisher's website |
999 |
_c27728981 _d27728981 |